Structure Therapeutics Inc.
GPCR
$56.65
$2.905.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -141.20M | -210.69M | -178.95M | -143.32M | -122.53M |
| Total Depreciation and Amortization | 1.68M | 1.21M | 1.11M | 1.05M | 996.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.37M | 9.97M | 5.44M | 3.16M | 1.93M |
| Change in Net Operating Assets | -88.04M | 5.26M | 9.45M | 4.33M | 2.96M |
| Cash from Operations | -222.20M | -194.25M | -162.95M | -134.79M | -116.64M |
| Capital Expenditure | -3.61M | -2.13M | -1.25M | -1.44M | -1.29M |
| Sale of Property, Plant, and Equipment | 10.25M | 5.16M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.16M | 63.86M | -71.59M | -324.85M | -357.62M |
| Cash from Investing | 89.80M | 66.89M | -72.84M | -326.29M | -358.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 765.15M | 59.53M | 2.49M | 517.27M | 517.06M |
| Repurchase of Common Stock | -618.00K | -618.00K | -156.00K | -156.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.02M | -770.00K | -1.15M | -1.74M | -1.80M |
| Cash from Financing | 762.52M | 58.14M | 1.18M | 515.37M | 515.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 630.11M | -69.22M | -234.60M | 54.29M | 39.72M |